June 21, 2024In the quest to combat Alzheimer's disease, George Mason professor Abolfazl Safikhani is working with neuroscientists and imaging experts at the University of Washington’s Alzheimer's Disease Research Center (ADRC) to pioneer groundbreaking advancements in biomarker identification.
